Biomedicines, Free Full-Text
Por um escritor misterioso
Descrição
Alpha-synuclein’s role in diseases termed “synucleinopathies”, including Parkinson’s disease, has been well-documented. However, after over 25 years of research, we still do not fully understand the alpha-synuclein protein and its role in disease. In vitro cellular models are some of the most powerful tools that researchers have at their disposal to understand protein function. Advantages include good control over experimental conditions, the possibility for high throughput, and fewer ethical issues when compared to animal models or the attainment of human samples. On the flip side, their major disadvantages are their questionable relevance and lack of a “whole-brain” environment when it comes to modeling human diseases, such as is the case of neurodegenerative disorders. Although now, with the advent of pluripotent stem cells and the ability to create minibrains in a dish, this is changing. With this review, we aim to wade through the recent alpha-synuclein literature to discuss how different cell culture setups (immortalized cell lines, primary neurons, human induced pluripotent stem cells (hiPSCs), blood–brain barrier models, and brain organoids) can help us understand aggregation pathology in Parkinson’s and other synucleinopathies.
Serial Para Internet Manager 6.21 - Colaboratory
Biomedical Informatics: Computer by Richard W. Bulliet
MDPI Article Template - Overleaf, Online LaTeX Editor
Articles by Sajjad Ahmad's Profile, Freelance Journalist
Gut microbiota and its metabolites in depression: from
Boxplots for illustration of cell numbers in stimulated and
Frontiers A Critical Perspective on 3D Liver Models for Drug
Collaboration with Generate Biomedicines
Biomedicines An Open Access Journal from MDPI
Biomedicines (ISSN 2227-9059, IF: 6.081) Questionnaire
Physical and Mental Activity, Disease Susceptibility, and Risk of
de
por adulto (o preço varia de acordo com o tamanho do grupo)